3m1o: Revision history

6 September 2023

• curprev 08:4708:47, 6 September 2023 OCA talk contribs 7,241 bytes −515 No edit summary

4 May 2022

• curprev 13:4313:43, 4 May 2022 OCA talk contribs 7,756 bytes +161 No edit summary

8 November 2017

• curprev 08:0308:03, 8 November 2017 OCA talk contribs 7,595 bytes −47 No edit summary

5 August 2016

• curprev 02:2802:28, 5 August 2016 OCA talk contribs 7,642 bytes +140 No edit summary

18 December 2014

• curprev 18:0118:01, 18 December 2014 OCA talk contribs 7,502 bytes +2,843 No edit summary

25 March 2013

• curprev 07:2107:21, 25 March 2013 OCA talk contribs 4,659 bytes +3,707 No edit summary

20 October 2012

• curprev 18:0818:08, 20 October 2012 OCA talk contribs 952 bytes −21 No edit summary

27 July 2012

• curprev 03:0803:08, 27 July 2012 OCA talk contribs m 973 bytes 0 Protected "3m1o" [edit=sysop:move=sysop]
• curprev 03:0803:08, 27 July 2012 OCA talk contribs 973 bytes −572 No edit summary

8 December 2010

• curprev 08:0908:09, 8 December 2010 OCA talk contribs 1,545 bytes 0 No edit summary

17 November 2010

• curprev 21:3821:38, 17 November 2010 OCA talk contribs 1,545 bytes +1,245 No edit summary

10 November 2010

• curprev 03:1603:16, 10 November 2010 OCA talk contribs 300 bytes −6 No edit summary

12 May 2010

• curprev 07:4407:44, 12 May 2010 OCA talk contribs 306 bytes +24 No edit summary

17 March 2010

• curprev 07:1207:12, 17 March 2010 OCA talk contribs 282 bytes +282 New page: '''Unreleased structure''' The entry 3m1o is ON HOLD Authors: Kolstoe, S.E., Wood, S.P. Description: Human Transthyretin (TTR) complexed with 2-((3,5-dichloro-4-hydroxyphenyl)amino)ben...